Kidney Cancer 

The physicians on the staff of Mount Sinai Urology Associates are fellowship-educated clinicians and researchers who are leaders in advancing emerging diagnostic techniques and treatments for kidney cancer. Our approach is multidisciplinary. We partner with our distinguished colleagues in the Department of Radiation Oncology, the Department of Medicine, and at Mount Sinai’s Tisch Cancer Institute to ensure we are providing comprehensive, personalized, and coordinated treatment. 

Experts in Minimally Invasive Techniques

Surgery is a critical therapeutic avenue in the management of kidney cancer as it may be curative in patients with early stage disease and may play an important diagnostic and therapeutic role for those with more advanced cancer. We are trained in open, laparoscopic, and robotic surgery. This combination of expertise makes us uniquely qualified to recommend the optimal approach for each patient, and our outcomes are among the best anywhere. 

Our depth of experience is unsurpassed. We have performed more than 1,500 full and partial nephrectomies. Utilizing minimally invasive techniques such as robotic partial nephrectomy, we can remove cancer while preserving healthy tissue and maintaining kidney function. Our results using robot-assisted kidney cancer surgery and other minimally invasive techniques have been nothing short of remarkable. 

Mount Sinai surgeons utilize other minimally invasive techniques for select patient populations. Radiofrequency ablation and cryrosurgery are sometimes used for patients for whom surgery would be too risky or for patients with very small tumors. For some patients, neither surgery nor medical intervention is recommended as first line treatment. Rather, active surveillance with oversight by a team of professionals can offer the option to delay surgery for small growths.

Dr. Michael Palese is the Director of Minimally Invasive Urology at Mount Sinai. The focus of his practice is kidney cancer and the reconstruction of kidney abnormalities in adults. He is one of only a handful of surgeons in the United States trained in robotic, laparoscopic, endoscopic, and open surgery. Dr. Palese established the robotic surgery program for kidney disease at Mount Sinai and has performed more than 4,000 surgeries to treat the full spectrum of kidney disorders. 

A hallmark of Mount Sinai Urology Associates is the direct involvement of patients. We spend time discussing the benefits and risks associated with each treatment option but encourage patients to become as knowledgeable as possible about their condition so the conversation can be truly two-way. 

We can help 

Please call us at 212-241-4812 to learn how our physicians can provide an in-depth evaluation to ensure optimal treatment for you or your loved one based on your medical profile and needs.